Drug Profile
Research programme: serotonin 6 receptor antagonists - Eli Lilly and Company
Alternative Names: 5-HT6 receptor antagonists - Eli Lilly and Company; diF-BAMPILatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Benzenesulfonates; Small molecules
- Mechanism of Action Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in USA (PO)
- 01 Apr 2005 Preclinical trials in Cognition disorders in USA (PO)